成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ANTI-CD2

ANTI-CD2 Struktur
CAS-Nr.
Englisch Name:
ANTI-CD2
Synonyma:
ANTI-CD2;ANTI-LFA-2;ANTI-HUMAN CD2;ANTI-HUMAN T11;ANTI-CD2, HUMAN;ANTI-HUMAN LFA-2;ANTI-T11 (HUMAN);Anti-CD2 antigen;ANTI-LFA-2 (HUMAN);Anti-LFA-3 receptor
CBNumber:
CB7178797
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

ANTI-CD2 Eigenschaften

storage temp. 
2-8°C
Aggregatzustand
buffered aqueous solution
Biologische Quelle
rabbit

Sicherheit

Kennzeichnung gef?hrlicher Xn
R-S?tze: 22

ANTI-CD2 Chemische Eigenschaften,Einsatz,Produktion Methoden

ANTI-CD2 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

ANTI-CD2 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 32)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Atlas antibodies 46-854595850
order@atlasantibodies.com China 29669 58
Merck KGaA (+86) 21 2033 8288
sigmaname@qq.com CHINA 292394 58
  • ANTI-LFA-2
  • ANTI-LFA-2 (HUMAN)
  • ANTI-HUMAN CD2/LFA-2, CLONE B-E2
  • ANTI-HUMAN CD2/LFA-2, CLONE B-E2, BIOTIN CONJUGATED
  • ANTI-HUMAN CD2/LFA-2, CLONE B-E2, MONOCLONAL ANTIBODY
  • ANTI-HUMAN CD2/LFA-2, CLONE B-E2, MONOCLONAL ANTIBODY, BIOTIN CONJUGATED
  • ANTI-HUMAN CD2, T-CELL
  • ANTI-HUMAN CD2
  • ANTI-HUMAN LFA-2
  • ANTI-HUMAN T11
  • ANTI-HUMAN T 11(2) (T 11, LFA-3 RECEPTOR)
  • ANTI-CD2, HUMAN, T-CELL
  • ANTI-CD2, HUMAN
  • ANTI-CD2 (HUMAN) MAB
  • ANTI-CD2, T-PAN (HUMAN)
  • ANTI-CD2
  • ANTI-T11 (HUMAN)
  • ANTI-T-CELLS, E ROSETTE RECEPTOR
  • Monoclonal Anti-CD2-FITC antibody produced in mouse
  • Monoclonal Anti-CD2-PE antibody produced in mouse
  • Anti-CD2 antibody produced in rabbit
  • Anti-CD2 antigen
  • Anti-Erythrocyte receptor
  • Anti-LFA-3 receptor
  • Anti-Rosette receptor
  • Anti-T-cell surface antigen CD2 precursor
  • Anti-T-cell surface antigen T11/Leu- 5
  • Monoclonal Anti-CD2 antibody produced in mouse
  • Monoclonal Anti-CD2-APC antibody produced in mouse
  • Monoclonal Anti-CD2-Biotin antibody produced in mouse
Copyright 2019 ? ChemicalBook. All rights reserved